8 years post-marketing surveillance between Asari Radix and hepatocellular carcinoma: Nationwide population-based evidence against an association

ConclusionsPost-marketing surveillance showed that Asari Radix has no relationship with HCC development at an intake of under 200 g. The study is persuasive in furthering our knowledge of the maximum allowable amount of Asari Radix.Graphical abstractStudy design for the non-HBV/HCV, HBV, and HCV cohorts. HBV, hepatitis B virus; HCV, hepaptitis C virus; HCC, hepatocellualr carcinoma; TCM, traditional Chinese medicine; NHIRD, National Health Insurance Research Database.
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research